{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:59:00Z","timestamp":1793059140437,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":4040,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.3945\/ajcn.111.024927","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T02:14:38Z","timestamp":1323310478000},"page":"297-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":613,"title":["Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study"],"prefix":"10.1016","volume":"95","author":[{"given":"W Timothy","family":"Garvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna H","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore M","family":"Gadde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley W","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.111.024927_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"10.3945\/ajcn.111.024927_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3810\/pgm.2009.11.2074","article-title":"The medical risks of obesity","volume":"121","author":"Pi-Sunyer","year":"2009","journal-title":"Postgrad Med"},{"key":"10.3945\/ajcn.111.024927_bib3","unstructured":"Delaet D, Schauer D. Obesity in adults. Clin Evid (Online) 2011. Available from: http:\/\/clinicalevidence.bmj.com\/ceweb\/index.jsp (cited 10 October 2011)."},{"key":"10.3945\/ajcn.111.024927_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.3945\/ajcn.111.024927_bib5","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1001\/jama.298.17.2028","article-title":"Cause-specific excess deaths associated with underweight, overweight, and obesity","volume":"298","author":"Flegal","year":"2007","journal-title":"JAMA"},{"key":"10.3945\/ajcn.111.024927_bib6","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"key":"10.3945\/ajcn.111.024927_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/hrt.2010.211201","article-title":"Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation","volume":"97","author":"Logue","year":"2011","journal-title":"Heart"},{"key":"10.3945\/ajcn.111.024927_bib8","unstructured":"National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services. Identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: National Heart, Lung, and Blood Institute, 2000. (NIH publication no. 00-4048.)"},{"key":"10.3945\/ajcn.111.024927_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003641.pub3","article-title":"Surgery for obesity","volume":"CD003641","author":"Colquitt","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3945\/ajcn.111.024927_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3810\/pgm.2011.01.2243","article-title":"The pharmacological treatment and management of obesity","volume":"123","author":"Hussain","year":"2011","journal-title":"Postgrad Med"},{"key":"10.3945\/ajcn.111.024927_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd2037","article-title":"Anti-obesity therapies","volume":"5","author":"Melnikova","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.3945\/ajcn.111.024927_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6-month randomized, placebocontrolled, dose-ranging trial of topiramate for weight loss in obesity","volume":"11","author":"Bray","year":"2003","journal-title":"Obes Res"},{"key":"10.3945\/ajcn.111.024927_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2337\/dc06-2001","article-title":"A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients","volume":"30","author":"Rosenstock","year":"2007","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.111.024927_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2005.03.053","article-title":"Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension","volume":"96","author":"Tonstad","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.3945\/ajcn.111.024927_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.ijo.0803382","article-title":"Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Toplak","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.3945\/ajcn.111.024927_bib16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects","volume":"28","author":"Wilding","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.3945\/ajcn.111.024927_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.3945\/ajcn.111.024927_bib18","unstructured":"Brownell K. The LEARN program for weight management. Dallas, TX: The Life Style Company, 2000."},{"issue":"suppl 1","key":"10.3945\/ajcn.111.024927_bib19","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142007","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.3945\/ajcn.111.024927_bib20","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142011","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.111.024927_bib21","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.3945\/ajcn.111.024927_bib22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.3945\/ajcn.111.024927_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.3945\/ajcn.111.024927_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"10.3945\/ajcn.111.024927_bib25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1368-5031.2005.00704.x","article-title":"Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications","volume":"59","author":"Petrilla","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.3945\/ajcn.111.024927_bib26","unstructured":"Medical Dictionary for Regulatory Activities. Available from: http:\/\/www.meddramsso.com\/ (cited 10 December 2010)."},{"key":"10.3945\/ajcn.111.024927_bib27","doi-asserted-by":"crossref","first-page":"e18582","DOI":"10.1371\/journal.pone.0018582","article-title":"Waist circumference as compared with body-mass index in predicting mortality from specific causes","volume":"6","author":"Leitzmann","year":"2011","journal-title":"PLoS ONE"},{"key":"10.3945\/ajcn.111.024927_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.111.024927_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The DaQing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.111.024927_bib30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.111.024927_bib31","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","article-title":"The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.111.024927_bib32","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.111.024927_bib33","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/j.1467-789X.2010.00807.x","article-title":"Obesity, weight loss and conditional cardiovascular risk factors","volume":"12","author":"Tzotzas","year":"2011","journal-title":"Obes Rev"},{"key":"10.3945\/ajcn.111.024927_bib34","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMct067019","article-title":"Bariatric surgery for morbid obesity","volume":"356","author":"DeMaria","year":"2007","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.111.024927_bib35","unstructured":"International Diabetes Federation Consensus Panel. Bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes: a position statement from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Available from: http:\/\/www.sicob.org\/00_materiali\/IDF_Position_Statement.pdf (cited 10 October 2011)."}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523026667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523026667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/95\/2\/297\/23815901\/297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:03:07Z","timestamp":1740762187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523026667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0002916523026667"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.111.024927","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.111.024927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Nutrition. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}